Provided by Tiger Fintech (Singapore) Pte. Ltd.

AEON Biopharma

0.4304
-0.0296-6.43%
Post-market: 0.43990.0095+2.21%19:58 EDT
Volume:215.36K
Turnover:96.79K
Market Cap:4.53M
PE:0.01
High:0.4672
Open:0.4672
Low:0.4302
Close:0.4600
Loading ...

AEON Co. Announces Strategic Acquisition of TSURUHA HOLDINGS

TIPRANKS
·
11 Apr

AEON Co. Reports Strong March Sales Amid Market Challenges

TIPRANKS
·
10 Apr

AEON Financial Service Announces Leadership Change

TIPRANKS
·
10 Apr

AEON Delight Co. Announces Reelection of Directors and Auditors

TIPRANKS
·
10 Apr

AEON Delight Reports Financial Growth Amid Upcoming Delisting

TIPRANKS
·
10 Apr

Hankyu Hanshin REIT Adjusts AEON MALL INAGAWA Acquisition Date

TIPRANKS
·
07 Apr

AEON Credit Service (Asia) Full Year 2025 Earnings: EPS Misses Expectations

Simply Wall St.
·
05 Apr

AEON Co. Revises Earnings Forecast Amid Record Revenue and Profit Challenges

TIPRANKS
·
04 Apr

AEON Credit Service Enhances Audit Committee Oversight

TIPRANKS
·
03 Apr

AEON Credit Service's 2024 Profit Rises

MT Newswires Live
·
03 Apr

AEON Credit Service Announces Final Dividend for FY 2025

TIPRANKS
·
03 Apr

AEON Stores Enters New Agreements with ATV Japan for Continued Collaboration

TIPRANKS
·
02 Apr

AEON Stores Reports Increased Losses in 2024 Annual Results

TIPRANKS
·
28 Mar

BRIEF-Aeon Biopharma Announces CEO Transition

Reuters
·
28 Mar

AEON Biopharma Announces CEO Resignation and Interim Appointment

TIPRANKS
·
28 Mar

AEON Biopharma Inc - Marc Forth Steps Down as President and CEO Effective April 4, 2025

THOMSON REUTERS
·
28 Mar

AEON Biopharma Inc - Jost Fischer Appointed Interim CEO

THOMSON REUTERS
·
28 Mar

AEON Biopharma Announces CEO Transition

THOMSON REUTERS
·
28 Mar

Press Release: AEON Biopharma Announces CEO Transition

Dow Jones
·
28 Mar

AEON Biopharma Q4 2024 GAAP EPS $3.75 Up From $(50.81) YoY

Benzinga
·
25 Mar